This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Bio-Rad Europe Gmbh, Bio-Rad Laboratories, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: The Innovations of Isabelle Batxelli-Molina
Introduction
Isabelle Batxelli-Molina is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of medical diagnostics, particularly in the evaluation of liver diseases. Her work focuses on innovative methods that enhance the diagnosis and treatment of conditions such as Non-Alcoholic Steatohepatitis (NASH).
Latest Patents
Isabelle holds a patent for "Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status." This invention provides a method for diagnosing NASH and assessing the hepatic fibrosis status of individuals, especially those suffering from Non-Alcoholic Fatty Liver Disease (NAFLD) or NASH. The method is based on the levels of three or more specific biomarkers. Additionally, the invention includes a kit designed for performing this diagnostic method and outlines treatment methods for patients diagnosed using these techniques. She has 1 patent to her name.
Career Highlights
Throughout her career, Isabelle has worked with prominent companies in the biotechnology sector. Notably, she has been associated with Bio-Rad Europe GmbH and Bio-Rad Laboratories, Inc. Her experience in these organizations has contributed to her expertise in medical diagnostics and innovation.
Collaborations
Isabelle has collaborated with several professionals in her field, including Florian Salipante and Roger P. Walker. These collaborations have further enriched her research and development efforts.
Conclusion
Isabelle Batxelli-Molina is a pioneering inventor whose work in medical diagnostics has the potential to significantly impact the evaluation and treatment of liver diseases. Her innovative approach to using biomarker combinations exemplifies the advancements being made in the field of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
